Table 2 Adverse events
|  | Placebo (n = 30) | Dexmedetomidine (n = 30) | P |
|---|---|---|---|
Bradycardia, n (%) | 0 (0.0) | 0 (0.0) | > 0.999 |
Bradycardia with intervention, n (%) | 0 (0.0) | 0 (0.0) | > 0.999 |
Hypotension, n (%) | 0 (0.0) | 1 (3.3) | > 0.999 |
Hypotension with intervention, n (%) | 0 (0.0) | 1 (3.3) | > 0.999 |
Tachycardia, n (%) | 7 (23.3) | 3 (10.0) | 0.299 |
Tachycardia with intervention, n (%) | 4 (13.3) | 2 (6.7) | 0.671 |
Hypertension, n (%) | 7 (23.3) | 1 (3.3) | 0.052 |
Hypertension with intervention, n (%) | 5 (16.7) | 1 (3.3) | 0.159 |
Respiratory depression, n (%) | 4 (13.3) | 3 (10.0) | > 0.999 |
Respiratory depression with intervention, n (%)* | 1 (3.3) | 0 (0.0) | > 0.999 |
Desaturation, n (%) | 2 (6.7) | 1 (3.3) | > 0.999 |
Desaturation with intervention, n (%)* | 1 (3.3) | 0 (0.0) | > 0.999 |
Unconsciousness, n (%) | 1 (3.3) | 0 (0.0) | > 0.999 |
Unconsciousness with intervention, n (%)* | 1 (3.3) | 0 (0.0) | > 0.999 |